Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04891614 · ClinicalTrials.gov registry record · NA
The PRISM Pilot Trial for Post-Traumatic Stress Disorder
A NA study, sponsored by GrayMatters Health.
- Completed
- Registry status
- NA
- Development phase
- 87
- Enrollment target
NCT04891614 is a NA study that has completed, run by GrayMatters Health. The registered enrollment target is 87 participants.
The verdict
NCT04891614, a NA study, has completed, sponsored by GrayMatters Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 87 participants
- Enrollment target
Study Summary
A Prospective, Single-Arm, Open-Label Pilot Trial, to Assess Safety and Effectiveness of Process-Instructed Self neuro-Modulation ("Prism"), as an Adjunct to Standard of Care, in Subjects with Post-Traumatic Stress Disorder (PTSD)
Interventions
- DEVICE PRISM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2020-11-29 |
| Est. Completion | 2022-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04891614
The ClinicalTrials.gov registry entry for NCT04891614 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GrayMatters Health, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PRISM is the first listed.
NCT04891614 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04891614 about?
NCT04891614 is a clinical study titled "The PRISM Pilot Trial for Post-Traumatic Stress Disorder". A Prospective, Single-Arm, Open-Label Pilot Trial, to Assess Safety and Effectiveness of Process-Instructed Self neuro-Modulation ("Prism"), as an Adjunct to Standard of Care, in Subjects with Post-Traumatic Stress Disorder (PTSD)
What is the current status of trial NCT04891614?
This trial is currently completed. It is a NA study. The enrollment target is 87 participants. The study started on 2020-11-29. Estimated completion is 2022-06-01.
What interventions are being tested in trial NCT04891614?
The interventions under investigation include: PRISM (DEVICE).
Who is sponsoring clinical trial NCT04891614?
This trial is sponsored by GrayMatters Health, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.